NO126299B - - Google Patents

Download PDF

Info

Publication number
NO126299B
NO126299B NO03424/68A NO342468A NO126299B NO 126299 B NO126299 B NO 126299B NO 03424/68 A NO03424/68 A NO 03424/68A NO 342468 A NO342468 A NO 342468A NO 126299 B NO126299 B NO 126299B
Authority
NO
Norway
Prior art keywords
dicloxacillin
wax
penicillin
ethyl cellulose
sodium
Prior art date
Application number
NO03424/68A
Other languages
English (en)
Norwegian (no)
Inventor
Alphonse Peter Granatek
Nicholas George Athanas
Michael Paul Demurino
Bernard Charles Nunning
Raymond George Daoust
Robert Lewis Dana
Edmund Stanley Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO126299B publication Critical patent/NO126299B/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO03424/68A 1964-05-20 1968-09-04 NO126299B (en, 2012)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36899164A 1964-05-20 1964-05-20
US66529767A 1967-09-05 1967-09-05
US67998267A 1967-11-02 1967-11-02
US68000867A 1967-11-02 1967-11-02

Publications (1)

Publication Number Publication Date
NO126299B true NO126299B (en, 2012) 1973-01-22

Family

ID=31950768

Family Applications (1)

Application Number Title Priority Date Filing Date
NO03424/68A NO126299B (en, 2012) 1964-05-20 1968-09-04

Country Status (11)

Country Link
BE (1) BE719923A (en, 2012)
DE (1) DE1792365A1 (en, 2012)
DK (1) DK125623B (en, 2012)
FI (1) FI48039C (en, 2012)
FR (1) FR1605499A (en, 2012)
GB (1) GB1246489A (en, 2012)
IE (1) IE32916B1 (en, 2012)
IL (1) IL30627A (en, 2012)
NL (1) NL141779B (en, 2012)
NO (1) NO126299B (en, 2012)
SE (1) SE363974B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153123B (da) * 1975-03-07 1988-06-20 Beecham Group Ltd Fremgangsmaade til fremstilling af et pulverformigt farmaceutisk praeparat indeholdende amoxycillin-trihydrat

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598458A (en) * 1977-04-01 1981-09-23 Hoechst Uk Ltd Tableting of microcapsules
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153123B (da) * 1975-03-07 1988-06-20 Beecham Group Ltd Fremgangsmaade til fremstilling af et pulverformigt farmaceutisk praeparat indeholdende amoxycillin-trihydrat

Also Published As

Publication number Publication date
DE1792365A1 (de) 1972-03-09
NL141779B (nl) 1974-04-16
FI48039C (fi) 1974-06-10
IL30627A (en) 1973-02-28
FR1605499A (en, 2012) 1977-06-24
NL6812651A (en, 2012) 1969-03-07
GB1246489A (en) 1971-09-15
IE32916B1 (en) 1974-01-23
IL30627A0 (en) 1968-10-24
SE363974B (en, 2012) 1974-02-11
BE719923A (en, 2012) 1969-02-24
DK125623B (da) 1973-03-19
FI48039B (en, 2012) 1974-02-28
IE32916L (en) 1969-05-02

Similar Documents

Publication Publication Date Title
JP6857467B2 (ja) 医薬品有効成分の粒子加工のための方法
US4835187A (en) Spray dried ibuprofen
ES2204109T3 (es) Composicion farmaceutica de topiramato.
TW579298B (en) Coating
JP2013510813A (ja) プロパン−１−スルホン酸｛３−［５−（４−クロロ−フェニル）−１Ｈ−ピロロ［２，３−ｂ］ピリジン−３−カルボニル］−２，４−ジフルオロ−フェニル｝−アミド組成物とその用途
NO310703B1 (no) Fremgangsmåte for fremstilling av tablettformulering som omfatter amoxycillin og klavulanat
CN107344927A (zh) Tafamidis葡甲胺盐的晶型E及其制备方法和用途
EP0222914A1 (en) Stabilized composite granular antibiotic preparation
CN109988164A (zh) 盐酸小檗碱与苹果酸共晶物及制备方法和其组合物与用途
JP2007532511A (ja) 低用量医薬品
FI58068C (fi) Foerfarande foer framstaellning av en hoegverksam snabbt resorberbar beredningsform av n-4-(2-(5-klor-2-metoxibensamido)-etyl)-fenyl-sulfonyl-n'-cyklohexylkarbamid
RU2017136999A (ru) Фармацевтическая композиция, содержащая силибин и экстракт корня пуэрарии
US3549746A (en) Antibiotic composition
CN110041325A (zh) 盐酸小檗碱与布洛芬共晶物及制备方法和其组合物与用途
NO126299B (en, 2012)
JPH07267850A (ja) 不快味を防止した医薬組成物及びその製造方法
CN107595782A (zh) 一种利奈唑胺干混悬剂及其制备方法
KR102342819B1 (ko) 마이크로 점적 환제의 제형 및 이의 제조방법
CN109988104B (zh) 山奈酚与异烟酰胺共晶物及制备方法和其药物组合物与用途
CN1303065C (zh) 氨溴索半胱氨酸类似物盐及其制备方法和用途
CN108245684A (zh) 一种薄荷醇羟丙基倍他环糊精包合物的制备方法
US3626056A (en) Oral antibiotic product
CN111214456A (zh) 伏立康唑干混悬剂及其制备方法
CN101708173B (zh) 一种软胶囊制剂及其应用
DK150604B (da) Analogifremgangsmaade til fremstilling af calciumoxaprozin